BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 35503461)

  • 21. Long-term follow-up on National Cancer Institute Phase I/II study of glioblastoma multiforme treated with iododeoxyuridine and hyperfractionated irradiation.
    Goffman TE; Dachowski LJ; Bobo H; Oldfield EH; Steinberg SM; Cook J; Mitchell JB; Katz D; Smith R; Glatstein E
    J Clin Oncol; 1992 Feb; 10(2):264-8. PubMed ID: 1310102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
    Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxic cell radiosensitizers in the treatment of malignant brain tumors.
    Gutin PH; Wara WM; Phillips TL; Wilson CB
    Neurosurgery; 1980 May; 6(5):567-76. PubMed ID: 6251398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensity-modulated radiation therapy with hypoxic sensitizer AK-2123 (sanazole) for glioblastoma multiforme using simultaneous integrated boost technique.
    Yamazaki H; Nakamura S; Nishimura T; Okabe H; Aibe N; Yoshida K; Kagiya T
    Anticancer Res; 2013 Apr; 33(4):1685-8. PubMed ID: 23564816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Landscape and Future Prospects of Radiation Sensitizers for Malignant Brain Tumors: A Systematic Review.
    Beg U; Snyder BM; Madhani SI; Hamidi N; Padmanaban V; Tuanquin LC; Kruser TJ; Connor J; Mansouri A
    World Neurosurg; 2021 Jul; 151():e839-e856. PubMed ID: 33974987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemoradiation for malignant brain tumors].
    Matsutani M
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2042-8. PubMed ID: 9388512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arsenic trioxide sensitizes cancer stem cells to chemoradiotherapy. A new approach in the treatment of inoperable glioblastoma multiforme.
    Tomuleasa C; Soritau O; Kacso G; Fischer-Fodor E; Cocis A; Ioani H; Timis T; Petrescu M; Cernea D; Virag P; Irimie A; Florian IS
    J BUON; 2010; 15(4):758-62. PubMed ID: 21229642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined modality treatment of glioblastoma multiforme: the role of temozolomide.
    Nieder C; Adam M; Grosu AL
    Rev Recent Clin Trials; 2006 Jan; 1(1):43-51. PubMed ID: 18393779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Success and Failures of Combined Modalities in Glioblastoma Multiforme: Old Problems and New Directions.
    Corso CD; Bindra RS
    Semin Radiat Oncol; 2016 Oct; 26(4):281-98. PubMed ID: 27619250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time and dose-dependent radiosensitization of the glioblastoma multiforme U251 cells by the EGF receptor tyrosine kinase inhibitor ZD1839 ('Iressa').
    Stea B; Falsey R; Kislin K; Patel J; Glanzberg H; Carey S; Ambrad AA; Meuillet EJ; Martinez JD
    Cancer Lett; 2003 Dec; 202(1):43-51. PubMed ID: 14643025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deregulated MicroRNA Signature Following Glioblastoma Irradiation.
    Toraih EA; El-Wazir A; Abdallah HY; Tantawy MA; Fawzy MS
    Cancer Control; 2019; 26(1):1073274819847226. PubMed ID: 31046428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial: Hypoxic cell radiosensitizers.
    Belli JA; Hellman S
    N Engl J Med; 1976 Jun; 294(25):1399-400. PubMed ID: 177876
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90.
    Dungey FA; Caldecott KW; Chalmers AJ
    Mol Cancer Ther; 2009 Aug; 8(8):2243-54. PubMed ID: 19671736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
    Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme.
    Levin VA; Maor MH; Thall PF; Yung WK; Bruner J; Sawaya R; Kyritsis AP; Leeds N; Woo S; Rodriguez L
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):357-64. PubMed ID: 7673023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme.
    Larner J; Jane J; Laws E; Packer R; Myers C; Shaffrey M
    Am J Clin Oncol; 1998 Dec; 21(6):579-83. PubMed ID: 9856659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy and chemotherapy with or without carbogen and nicotinamide in inoperable biopsy-proven glioblastoma multiforme.
    Simon JM; Noël G; Chiras J; Hoang-Xuan K; Delattre JY; Baillet F; Mazeron JJ
    Radiother Oncol; 2003 Apr; 67(1):45-51. PubMed ID: 12758239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere targeting with a new G4 ligand enhances radiation-induced killing of human glioblastoma cells.
    Merle P; Evrard B; Petitjean A; Lehn JM; Teulade-Fichou MP; Chautard E; De Cian A; Guittat L; Tran PL; Mergny JL; Verrelle P; Tchirkov A
    Mol Cancer Ther; 2011 Oct; 10(10):1784-95. PubMed ID: 21987532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
    Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
    J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.